BamSEC and AlphaSense Join Forces
Learn More

Context Therapeutics Inc. – Articles of Incorporation

NASDAQ: CNTX    
Share price (7/8/26): $0.60    
Market cap (7/8/26): $54.7 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K 2 pages Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Context Therapeutics Inc
12/34/56
EX-3.1
from 10-K 6 pages Amended and Restated Certificate of Incorporation of Context Therapeutics Inc
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Correction of Amended and Restated Certificate of Incorporation of Context Therapeutics Inc
12/34/56
EX-3.2
from 8-K 6 pages Amended and Restated Certificate of Incorporation of Context Therapeutics Inc
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment to the Certificate of Incorporation of Context Therapeutics Inc
12/34/56
EX-3.2
from 10-K 27 pages Amended and Restated Bylaws of Context Therapeutics Inc
12/34/56
EX-3.1
from 8-K 33 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.2
from 8-K 30 pages Amended and Restated Bylaws of Context Therapeutics Inc
12/34/56
EX-3.1
from 8-K 7 pages Amended and Restated Certificate of Incorporation of Context Therapeutics Inc
12/34/56
EX-3.2
from S-1/A 2 pages Certificate of Amendment of Certificate of Incorporation of Context Therapeutics Inc
12/34/56
EX-3.5
from S-1/A 30 pages Amended and Restated Bylaws of Context Therapeutics Inc
12/34/56
EX-3.3
from S-1/A 8 pages Amended and Restated Certificate of Incorporation of Context Therapeutics Inc
12/34/56
EX-3.3
from S-1 13 pages Offices, Corporate Seal
12/34/56
EX-3.1
from S-1 25 pages Certificate of Incorporation of Context Therapeutics Inc
12/34/56
EX-3.3
from DRS/A 13 pages Offices, Corporate Seal
12/34/56